New PBS listing addresses clinical inertia in type 2 diabetes, says expert

The change allows patients to step up their glycaemic management

Recent changes to the PBS support patients with type 2 diabetes and uncontrolled HbA1c to step up their glycaemic management, according to Dr Gary Deed, a GP with a special interest in diabetes and chair of the RACGP Specific Interests Diabetes network.

Dr Gary Deed
Dr Gary Deed

Dr Deed says the extended PBS listing of the once-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA)